| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

API Innovation Center Announces New "Re-shoring" Strategy
By: PR Newswire Association LLC. - 03 Oct 2022Back to overview list

Glioblastoma Foundation advancing brain cancer treatment with Lomustine

NAM Manufacturing Institute to discuss Advanced Manufacturing and Workforce

WASHINGTON, Oct. 3, 2022 /PRNewswire/ --

What: National Press Club News Conference with Anthony Sardella, CEO and President of the API Innovation Center; Gita Kwatra, PharmD., Executive Director, Glioblastoma Foundation; Gardner Carrick, VP of the Manufacturing Institute of NAM.

When: Tuesday, Oct. 4, 1 p.m. to 2:30 p.m.

Where: National Press Club, 529 14th Street NW, Washington, D.C. 13th floor Holeman Lounge

Who: Tony Sardella will discuss a pathway to reshoring essential and critical drugs through advanced manufacturing, the national security of the American drug supply, and sharing new research findings on U.S. pharmaceutical excess manufacturing capacity. Gita Kwatra will discuss new research and continuous manufacturing of Lomustine, a compound used in the treatment of glioblastoma, a rare brain cancer, and make treatment more affordable and accessible. Gardner Carrick will provide insights on advanced manufacturing and the next generation workforce upskills required to meet these high technology jobs.


President Biden's Executive Order of Sept. 12 calls for: "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy." Experts from the API Innovation Center in St. Louis, a non-profit dedicated to strengthening US-sourced Active Pharmaceutical Ingredients (API), will discuss the immediate impact of this EO to secure our national public health and national security.

Media will be briefed on reshoring and the domestic production of vital pharmaceutical ingredients. One key ingredient in the battle against glioblastoma is Lomustine. The GF will present new information on breakthrough drugs. The global pharmaceutical supply chain is under-capacity. Now, advanced continuous manufacturing can create new workforce development opportunities, expand access to treatment, and make medications more affordable.

National Association of Manufacturers (NAM) and the Manufacturing Institute provides global-best workforce development through strong technical training, integration of manufacturing core competencies, intensive professional practices, and hands-on experience to build the future of the modern manufacturing industry.

API Innovation Center has recently received a $1 million grant from Biden's Build Back Better initiative to focus on these domestic supply chain issues.

For more information on the APIIC and its commitment to de-risk and safeguard the nation's API supply chain, visit:


Cision View original content:


Copyright 2022 PR Newswire Association LLC. Back to overview list
to the top ↑